Read more about Michelle Swift, PhD
Michelle Swift, PhD
...on how the tumor suppressor BRCA1 and its partner BARD1 regulate DNA repair through ubiquitin signaling. Specifically, I investigate how BRCA1/BARD1-mediated ubiquitination of anti-resection complexes modulates DNA end resection, replication...
Read more about Christina Curtin, MD
Christina Curtin, MD
2026 Mentored Investigator Grant Memorial Sloan Kettering Cancer Center Project Summary PARP inhibitor (PARPi) therapy has improved survival in high-grade serous ovarian cancer (HGSOC), especially in patients with BRCA1 and...
Read more about Richard Adeyemi, DVM, PhD
Richard Adeyemi, DVM, PhD
...lead to cancer. Certain patients inherit mutations in some of these critical genes, predisposing them to cancer. Two particular genes, BRCA1 and BRCA2, have been shown to be mutated often...